Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder CancerFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Non-Muscle Invasive Bladder Neoplasms, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, carcinoma, epithelial neoplasm, neoplasm, urinary bladder disorder, urinary bladder neoplasm, urinary system disorderRecruitingPhase 1 / Phase 22026-05-27NCT05710848

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
SURGE Therapeutics3

20 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Advanced Urology InstituteDaytona BeachUnited States10
Advent HealthOrlandoUnited States14
Anna Arundel UrologyAnnapolisUnited States1
Arizona Urology SpecialistsTucsonUnited States5
Arkansas UrologyLittle RockUnited States27
Baylor College of MedicineHoustonUnited States306
Brigham and Women's HospitalBostonUnited States511
Carolina Urologic Research CenterMyrtle BeachUnited States55
East Valley Urology Center of ArizonaMesaUnited States1
Genesis ResearchDowneyUnited States1
Houston MethodistHoustonUnited States63
Lowcountry UrologyNorth CharlestonUnited States1
Michigan Institute of UrologyTroyUnited States14
The Ohio State UniversityColumbusUnited States13
Unio Specialty Care - A Genesis Healthcare Partners FacilityBakersfieldUnited States1
University of FloridaGainesvilleUnited States70
University of Texas Health Science Center at San AntonioSan AntonioUnited States193
University of Texas Southwestern Medical CenterDallasUnited States249
Urology Center of Southern CaliforniaMurrietaUnited States1
Urology Partners of North TexasFort WorthUnited States1